SINGLE TYROSINE SUBSTITUTION IN THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR INHIBITS LIGAND-INDUCED RECEPTOR AUTOPHOSPHORYLATION AND INTERNALIZATION, BUT NOT MITOGENESIS
B. Stannard et al., SINGLE TYROSINE SUBSTITUTION IN THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR INHIBITS LIGAND-INDUCED RECEPTOR AUTOPHOSPHORYLATION AND INTERNALIZATION, BUT NOT MITOGENESIS, Endocrinology, 136(11), 1995, pp. 4918-4924
The tyrosine kinase domains of the insulin and insulin-like growth fac
tor I (IGF-I) receptors play an essential role in signal transduction.
After ligand binding, these receptors undergo autophosphorylation, wi
th a cluster of three tyrosines (residues 1131, 1135, and 1136 in the
IGF-I receptor) being the first to be phosphorylated. Mutation of the
ATP-binding site or substitution of this triple tyrosine cluster in th
e catalytic domain blocks essentially all of the functions of these re
ceptors. Using stably transfected NIH-3T3 cell lines, we studied the e
ffect of a mutation of tyrosine 1131 of the triple tyrosine cluster of
the IGF-I receptor to phenylalanine. This mutation significantly redu
ced IGF-I-induced beta-subunit autophosphorylation, whereas phosphoryl
ation of the endogenous substrate IRS-1 was unaffected. Despite the re
duction in autophosphorylation and receptor internalization, IGF-I-ind
uced thymidine incorporation and cellular proliferation were unaffecte
d. Thus, the extent of receptor autophosphorylation and internalizatio
n does not appear to be a limiting factor for IGF-I-stimulated mitogen
esis.